Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/23867Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kumari, Archana | - |
| dc.contributor.author | Kumar, Uday | - |
| dc.contributor.author | Agarwal, H C | - |
| dc.date.accessioned | 2013-11-20T06:00:52Z | - |
| dc.date.available | 2013-11-20T06:00:52Z | - |
| dc.date.issued | 2001-08 | - |
| dc.identifier.issn | 0975-1009 (Online); 0019-5189 (Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/23867 | - |
| dc.description | 811-813 | en_US |
| dc.description.abstract | Imidazole compound KK-42 was tested for its inhibitory effect on Schisfocerca gregaria. The compound caused 80% mortality after 19 days of treatment with 100 µg of KK-42/insect. It also caused the production of deformed adults at even lower doses. Ecdysteroid content, when estimated by RIA, declined due to KK-42 treatment in both haemolymph and ovaries of the insect. Reduction in ecdysteroid titer was maximum at 100 µg of KK-42/insect. The value estimated by RIA was 0.34 ng/µL haemolymph as compared to 0.97 ng/µL in case of controls. Similarly, ecdysteroid content of ovaries detected was 0.48 ng/mg in treated ones as compared to 0.61 ng/mg in control s. Histological studies, however, revealed no alteration in the ovarian tissues due to KK-42 treatment. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights | CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | IJEB Vol.39(08) [August 2001] | en_US |
| dc.title | Inhibitory effect of 1-benzyl-5[(C)-2,6-dimethyl-1,5-heptadienyl] imidazole (KK-42) on desert locust, Schistocerca gregaria Forsk. | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJEB Vol.39(08) [August 2001] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB 39(8) 811-813.pdf | 723.37 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.